Search

everythinglearnresearchcommunity

for

Search:↓

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Early treatment helps stop hair loss in women of color.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Transplant patients often get skin problems, with treatments varying by condition.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Herbal medicine might be a good alternative for treating hair loss.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

The new technique effectively treats hairline vitiligo with repigmentation and hair regrowth.